Additional European Equity News

GSK (GSK LN) - FDA to review Gonorrhea indication for Gepotidacin; US decision exp. in Dec 2025. (Newswires) 

Plus 500 (PLUS LN) - Announced USD 165mln in shareholder returns. FY25 results are exp. to be in-line with current market expectations. (Newswires) 

Serco (SRP LN) - Announced up to GBP 50mln share buyback programme. (Newswires) 

S4 Capital (SFOR LN) - Co. confirms a proposal from MSQ Partners for combination - highlights discussions are at a prelim stage. (Newswires)